Legend Biotech

legendbiotech.com

Legend Biotech is a global, commercial-stage biotechnology company focused on developing, manufacturing, and commercializing innovative cell therapies for oncology. With a commitment to improving patient lives, the company is dedicated to exploring advanced technologies to treat intractable diseases, particularly hematologic malignancies and solid tumors. Their flagship product, CARVYKTI®, is a CAR T-cell therapy that has shown significant efficacy in treating multiple myeloma. The company aims to lead the cell therapy market by delivering transformative therapies that change treatment paradigms, supported by a robust pipeline and a team of over 1,000 experts.